Dr. Goldman is a Professor of Pediatrics, and the Division Head Hematology/Oncology, Neuro-oncology and Stem Cell Transplantation  and a faculty member of the Falk Brain Tumor Center at the Ann & Robert H Lurie children’s Hospital of Chicago , Northwestern University Feinberg School of Medicine. Dr. Goldman has a special interest in developing new therapies for the treatment of brain stem gliomas. 

Presently, he is the Principal Investigator in a multi-institutional trial of Optune TTFE for children with newly diagnosed brain stem gliomas. system (CNS) tumors. His laboratory investigations include examining the safety and efficacy of the photon radiosurgery system (PRS) for the treatment of pediatric brain tumors. He is investigating the effectiveness of intranasal chemotherapy for CNS tumors as well as  intratumoral  immunotherapy for DIPG. His special interests are in brain tumor survivorship issues (collaborating with  Drs. Lai and Cella), phase I/phase II developmental therapeutics, and clinical trials development. 

Investigator of Clinical Trial:  MV-NIS (NCT 02962167)